Thanks, Greg. The following pertains to the second quarter of fiscal year 2025, which is the quarter ended March 31, 2025. Please refer to the slide presentation titled Supplemental Information on our website and provided with our Form 8-K for reference with this discussion. On Tuesday, we announced the sale of our Healthcare RCM Business. The business we sold had approximately $39 million of revenues and approximately $8 million of adjusted EBITDA in our guidance for fiscal 2025. The sale will reduce our headcount by over 400 employees. This sale follows the sale of our Merchant Services Business last September, and we need to start by clarifying some labels and classifications. The sale of our Healthcare RCM Business did not qualify as assets held for sale or discontinued operations as of March 31, our current reporting period. As such, for financial reporting purposes, when you look at our earnings release or later our 10-Q, continuing operations refers to our results exclusive of the Merchant Services Business, but including the Healthcare RCM business. The Healthcare RCM business will then become discontinued operations as part of our Q3 reporting cycle, our June quarter, and we will be able to give more complete historical financial information related to the divested business then. For now, when we remove the impact of the divested Healthcare RCM Business, we will call that RemainCo and our discussion on our quarterly results in the outlook section will be focused there. RemainCo revenues for the second quarter of fiscal 2025 increased 11.6% to $54.1 million from $48.5 million for Q2 2024, reflecting $4.4 million of organic growth, or 9%, and $1.2 million of revenue from the permitting and licensing acquisition we made last year in the public sector. Growth for education revenues were in line with organic growth for RemainCo as a whole. Annual recurring revenues for RemainCo increased 9.2% to $164.5 million for Q2 2025 compared to $150.6 million for Q2 2024. 76% of our revenues from the quarter came from recurring sources driven by SaaS revenue growth of 23%, transaction based revenue growth of 8% and recurring software services growth of 12%. Non-recurring sales of software licenses for RemainCo increased to $2.8 million for Q2 2025 and just $1 million for Q2 2024. We expect software license sales to be lower for the second half of the fiscal year relative to the first half. RemainCo software and related services represented 70% of RemainCo revenues for Q2 with payments 26% and other 4%. Adjusted EBITDA for RemainCo increased 17%, outpacing revenues to $15.8 million for Q2 2025 from $13.5 million for Q2 2024. Adjusted EBITDA as a percentage of revenues was 29.3%, an increase from 27.9% for Q2 2024, reflecting higher software sales, which carry high margins. Regarding the balance sheet following the sale of our Merchant Services Business last September and the sale of our RCM Healthcare Business this week, our balance sheet is strong and well positioned for the future. As of March 31, net debt stood at $4 million. We repaid the balance of our convertible notes at maturity during February. Following quarter end, we purchased the Utility Billing Software Company for $9 million, which Rick will profile. We also paid an earn-out of $1.5 million associated with the divested Healthcare RCM Business and we sold the RCM Healthcare Business for $96 million plus transaction costs and taxes of almost $18 million. So we currently have a cash position of approximately $64 million. We still have $400 million of borrowing capacity under our revolving credit facility with a 5x leverage constraint. We intend to use the cash at any borrowings for acquisitions and potential stock repurchases. The following introduces guidance for RemainCo for fiscal 2025. The outlook does not include acquisitions or dispositions that have not been announced or transaction related costs. The Utility Billing Software acquisition is a high margin business and the price of $9 million was on the high end of our normal multiple range. The effective date was April 1st. Revenues $207 million to $217 million, adjusted EBITDA $56 million to $61 million, appreciation and internally developed software amortization $11 million to $12 million, cash interest expense $0 to $750,000, pro forma adjusted diluted earnings per share $0.96 to $1.06. In view of recent trade friction between the U.S. and Canada and ongoing delays with our Manitoba contract, we have removed about $2.5 million of revenues, which were previously included in our outlook for fiscal 2025, principally in the second half of the fiscal year. We still continue to expect high single digit organic revenue growth for RemainCo in the absence of the Healthcare RCM Business, and we continue to expect adjusted EBITDA margin improvement of 50 to 100 basis points per year. From a seasonality standpoint, we currently expect our revenue distribution for the remaining two quarter to approximate the following: Q3 48%, Q4 52%. Public sector payments and software services revenues declined seasonally during Q3 along with education revenues while school is out. Although software license sales are less a factor than in years past, they still represent the most variable line item to forecast and can distort seasonality in any given quarter. I will now turn the call over to Rick for comments on M&A.